Atrás

Watch Compare

ROCKWELL MEDICAL, INC.

Calidad de datos: 83%

RMTI

Nasdaq Manufacturing Chemicals

$0.94

▲ $0.00 (0.52%)

Cap. Mercado: 37.20 M

Precio

$0.94

Cap. Mercado

37.20 M

Rango del Día

$0.92 — $0.96

Rango de 52 Semanas

$0.78 — $2.10

Volumen

76,309

Apertura $0.94

Promedio 50D / 200D

$0.99

4.69% below

Promedio 50D / 200D

$1.07

11.49% below

Quick Summary

Puntos Clave

Debt/Equity of 0.24 — conservative balance sheet

Negative free cash flow of -659,000.0

Crecimiento

Revenue Growth (5Y)

N/A

Revenue (1Y)N/A

Earnings (1Y)N/A

FCF Growth (3Y)N/A

Calidad

Return on Equity

-15.76%

Above sector avg (-53.41%)

ROIC-8.27%

Net MarginN/A

Op. MarginN/A

Seguridad

Debt / Equity

0.24

Below sector avg (0.31)

Current Ratio3.92

Interest Coverage-4.17

Valoración

PE (TTM)

-7.00

Below sector avg (-1.48)

P/B Ratio1.00

EV/EBITDAN/A

Dividend YieldN/A

Historial de Precios

Tendencias Financieras

Comparación con Pares

vs mediana del sector Manufacturing (1364 pares)

Métrica	Acción	Mediana del Sector
P/E	-7.0	-1.5
P/B	1.0	1.6
ROE %	-15.8	-53.4
Net Margin %	—	-41.5
Rev Growth 5Y %	—	1.8
D/E	0.2	0.3

All Fundamental Metrics

Growth
Revenue Growth (1Y)	N/A	Revenue Growth (3Y)	N/A
Earnings Growth (1Y)	N/A	Earnings Growth (3Y)	N/A
Revenue Growth (5Y)	N/A	Earnings Growth (5Y)	N/A
Profitability
Revenue (TTM)	N/A	Net Income (TTM)	-5.31 M
ROE	-15.76%	ROA	-9.65%
Gross Margin	N/A	Operating Margin	N/A
Net Margin	N/A	Free Cash Flow (TTM)	-659,000.0
ROIC	-8.27%	FCF Growth (3Y)	N/A
Safety
Debt / Equity	0.24	Current Ratio	3.92
Interest Coverage	-4.17	Asset Turnover	N/A
Working Capital	27.93 M	Tangible Book Value	26.31 M
Dividends
Dividend Yield	N/A	Payout Ratio	N/A
Dividend Growth (3Y)	N/A	Dividend Growth (5Y)	N/A
Consecutive Div Years	N/A
Valuation
P/E Ratio	-7.00	Forward P/E	N/A
P/B Ratio	1.00	P/S Ratio	N/A
PEG Ratio	N/A	Forward PEG	N/A
EV/EBITDA	N/A	Fwd EV/EBITDA	N/A
Forward P/S	N/A	Fwd Earnings Yield	N/A
FCF Yield	-1.77%
Market Cap	37.20 M	Enterprise Value	32.33 M
Per Share
EPS (Diluted TTM)	-0.15	Revenue / Share	N/A
FCF / Share	-0.02	OCF / Share	-0.02
EPS CAGR (1Y)	N/A	EPS CAGR (5Y)	N/A
EPS CAGR (10Y)	N/A
Efficiency
CapEx / Revenue	N/A	FCF Conversion	12.40%
SBC-Adj. FCF	-2.34 M	Growth Momentum	N/A

Income Statement

Annual, most recent first

Metric	FY2025	FY2024	FY2023	FY2022	FY2021
Revenue	—	—	—	—	—
Net Income	-5.31 M	-480,000.0	-8.44 M	-18.68 M	-32.67 M
EPS (Diluted)	-0.15	-0.03	-0.37	-1.89	-0.35
Gross Profit	11.70 M	17.48 M	8.70 M	4.08 M	-2.42 M
Operating Income	-4.69 M	608,000.0	-6.67 M	-16.78 M	-30.34 M
EBITDA	—	—	—	—	—
R&D Expenses	0.0	19,000.0	—	—	—
SG&A Expenses	—	—	—	—	—
D&A	2.19 M	2.18 M	1.44 M	576,000.0	668,000.0
Interest Expense	1.12 M	1.25 M	2.30 M	1.94 M	2.36 M
Income Tax	0.0	0.0	0.0	0.0	0.0

Balance Sheet

Annual, most recent first

Metric	FY2025	FY2024	FY2023	FY2022	FY2021
Total Assets	57.15 M	59.21 M	52.17 M	46.64 M	48.57 M
Total Liabilities	20.16 M	26.62 M	30.88 M	32.53 M	46.04 M
Shareholders' Equity	36.98 M	32.59 M	21.29 M	14.11 M	2.54 M
Total Debt	8.83 M	8.47 M	8.29 M	7.56 M	13.19 M
Cash & Equivalents	10.71 M	15.66 M	8.98 M	10.10 M	13.28 M
Current Assets	38.16 M	37.03 M	28.77 M	35.31 M	35.29 M
Current Liabilities	9.58 M	14.09 M	16.64 M	17.69 M	20.97 M